Viewing StudyNCT06207734



Ignite Creation Date: 2024-05-06 @ 7:59 PM
Last Modification Date: 2024-10-26 @ 3:18 PM
Study NCT ID: NCT06207734
Status: RECRUITING
Last Update Posted: 2024-04-12
First Post: 2024-01-03

Brief Title: Discontinuation of CDK46 Inhibitors in Patients With Metastatic HR Positive HER2 Negative Breast Cancer
Sponsor: Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Organization: Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest

Organization Data

Organization: Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Class: OTHER
Study ID: DISCUSS
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Lead Sponsor Class: OTHER
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: SPONSOR
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators